| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PALISADE BIO, INC. | Director | Common Stock, par value $0.01 | 12.9K | $5.61K | $0.44 | Feb 8, 2024 | Direct |
| PALISADE BIO, INC. | Director | Restricted Stock Units | 0 | $0 | $0.44 | Feb 8, 2024 | Direct |
| IDERA PHARMACEUTICALS, INC. | Director | Stock Option (Right to Buy) | 26K | Jun 23, 2022 | Direct | ||
| PALISADE BIO, INC. | Director | Common Stock Options | 6.88K | Feb 8, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| PALI | PALISADE BIO, INC. | Feb 8, 2024 | 8 | $0 | 4 | Feb 13, 2024 | Director |
| PALI | PALISADE BIO, INC. | Nov 21, 2023 | 2 | $0 | 4 | Nov 24, 2023 | Director |
| PALI | PALISADE BIO, INC. | Jun 11, 2023 | 2 | $0 | 4 | Jun 13, 2023 | Director |
| IDRA | IDERA PHARMACEUTICALS, INC. | Jun 23, 2022 | 1 | $0 | 4 | Jun 27, 2022 | Director |
| PALI | PALISADE BIO, INC. | Nov 18, 2021 | 1 | $0 | 4 | Feb 10, 2022 | Director |
| IDRA | IDERA PHARMACEUTICALS, INC. | Jun 8, 2021 | 1 | $0 | 4 | Jun 10, 2021 | Director |